122 related articles for article (PubMed ID: 37581220)
1. Macrocyclic peptides as inhibitors of WDR5-lncRNA interactions.
Chang JY; Neugebauer C; Schmeing S; Amrahova G; 't Hart P
Chem Commun (Camb); 2023 Aug; 59(71):10656-10659. PubMed ID: 37581220
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA
Pistoni M; Rossi T; Donati B; Torricelli F; Polano M; Ciarrocchi A
Mol Cancer Res; 2021 May; 19(5):799-811. PubMed ID: 33547232
[TBL] [Abstract][Full Text] [Related]
3. LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern.
Sun TT; He J; Liang Q; Ren LL; Yan TT; Yu TC; Tang JY; Bao YJ; Hu Y; Lin Y; Sun D; Chen YX; Hong J; Chen H; Zou W; Fang JY
Cancer Discov; 2016 Jul; 6(7):784-801. PubMed ID: 27147598
[TBL] [Abstract][Full Text] [Related]
4. The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.
Ye X; Zhang R; Lian F; Zhang W; Lu W; Han J; Zhang N; Jin J; Luo C; Chen K; Ye F; Ding H
Bioorg Med Chem Lett; 2019 Feb; 29(4):638-645. PubMed ID: 30626558
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction.
Chen WL; Li DD; Chen X; Wang YZ; Xu JJ; Jiang ZY; You QD; Guo XK
Eur J Med Chem; 2020 Feb; 188():112027. PubMed ID: 31923859
[TBL] [Abstract][Full Text] [Related]
6. H3K4me2 and WDR5 enriched chromatin interacting long non-coding RNAs maintain transcriptionally competent chromatin at divergent transcriptional units.
Subhash S; Mishra K; Akhade VS; Kanduri M; Mondal T; Kanduri C
Nucleic Acids Res; 2018 Oct; 46(18):9384-9400. PubMed ID: 30010961
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.
Imran A; Moyer BS; Canning AJ; Kalina D; Duncan TM; Moody KJ; Wolfe AJ; Cosgrove MS; Movileanu L
Biochem J; 2021 Jun; 478(11):2145-2161. PubMed ID: 34032265
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9.
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2017 Dec; 410():68-81. PubMed ID: 28947139
[TBL] [Abstract][Full Text] [Related]
9. Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency.
Yang YW; Flynn RA; Chen Y; Qu K; Wan B; Wang KC; Lei M; Chang HY
Elife; 2014 Feb; 3():e02046. PubMed ID: 24521543
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTTIP enhances human osteogenic BMSCs differentiation via interaction with WDR5 and activation of Wnt/β-catenin signalling pathway.
Liu R; Li Z; Song E; Hu P; Yang Q; Hu Y; Liu H; Jin A
Biochem Biophys Res Commun; 2020 Apr; 524(4):1037-1043. PubMed ID: 32067741
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity.
Chen W; Chen X; Li D; Wang X; Long G; Jiang Z; You Q; Guo X
Eur J Med Chem; 2021 Nov; 223():113677. PubMed ID: 34225179
[TBL] [Abstract][Full Text] [Related]
12. Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes.
Alicea-Velázquez NL; Shinsky SA; Loh DM; Lee JH; Skalnik DG; Cosgrove MS
J Biol Chem; 2016 Oct; 291(43):22357-22372. PubMed ID: 27563068
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5.
Senisterra G; Wu H; Allali-Hassani A; Wasney GA; Barsyte-Lovejoy D; Dombrovski L; Dong A; Nguyen KT; Smil D; Bolshan Y; Hajian T; He H; Seitova A; Chau I; Li F; Poda G; Couture JF; Brown PJ; Al-Awar R; Schapira M; Arrowsmith CH; Vedadi M
Biochem J; 2013 Jan; 449(1):151-9. PubMed ID: 22989411
[TBL] [Abstract][Full Text] [Related]
14. Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex.
Shinsky SA; Cosgrove MS
J Biol Chem; 2015 Oct; 290(43):25819-33. PubMed ID: 26324722
[TBL] [Abstract][Full Text] [Related]
15. PHF20L1 antagonizes SOX2 proteolysis triggered by the MLL1/WDR5 complexes.
Wang Q; Yu M; Ma Y; Zhang X; Zhang H; Li S; Lan R; Lu F
Lab Invest; 2018 Dec; 98(12):1627-1641. PubMed ID: 30089852
[TBL] [Abstract][Full Text] [Related]
16. WD repeat-containing protein 5, a ubiquitously expressed histone methyltransferase adaptor protein, regulates smooth muscle cell-selective gene activation through interaction with pituitary homeobox 2.
Gan Q; Thiébaud P; Thézé N; Jin L; Xu G; Grant P; Owens GK
J Biol Chem; 2011 Jun; 286(24):21853-64. PubMed ID: 21531708
[TBL] [Abstract][Full Text] [Related]
17. High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction.
Karatas H; Townsend EC; Cao F; Chen Y; Bernard D; Liu L; Lei M; Dou Y; Wang S
J Am Chem Soc; 2013 Jan; 135(2):669-82. PubMed ID: 23210835
[TBL] [Abstract][Full Text] [Related]
18. Ectopic HOTTIP expression induces noncanonical transactivation pathways to promote growth and invasiveness in pancreatic ductal adenocarcinoma.
Wong CH; Li CH; He Q; Chan SL; Tong JH; To KF; Lin LZ; Chen Y
Cancer Lett; 2020 May; 477():1-9. PubMed ID: 32120024
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype.
Zhang C; Ge S; Gong W; Xu J; Guo Z; Liu Z; Gao X; Wei X; Ge S
Cell Death Dis; 2020 Jun; 11(6):435. PubMed ID: 32513988
[TBL] [Abstract][Full Text] [Related]
20. WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.
Song JJ; Kingston RE
J Biol Chem; 2008 Dec; 283(50):35258-64. PubMed ID: 18840606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
